OI are privately funded and with dismal sales they must ready for some more cash. FDA will cost quite a bit, the value of the military trials to CST was $M's.
Their next big hurdle is FDA, it took CST 12 months to get through the process with Gold and it looks like the same will apply to in-tube. And that is with all the supporting data from the military and CDC. FDA like to run a fine tooth comb over the presentation and they may not appreciate the combination of 2 products for the OI application, T-Spot TB and Elispot. Elispot has been licensed in the US for years, for research only. Elispot is not a OI product and therefore cannot form part of the FDA process.
It will be interesting times for OI, my money is on the FDA throwing out the application.
CST Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held
